BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2014 3:08:00 PM | Browse: 1230 | Download: 1674
 |
Received |
|
2013-09-28 16:49 |
 |
Peer-Review Started |
|
2013-09-29 14:10 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2013-10-31 10:03 |
 |
Revised |
|
2013-11-18 04:37 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2013-12-16 13:47 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2013-12-16 13:51 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
2013-12-20 01:37 |
 |
Typeset the Manuscript |
|
2014-03-25 17:57 |
 |
Publish the Manuscript Online |
|
2014-03-26 14:31 |
| Category |
Hematology |
| Manuscript Type |
Minireviews |
| Article Title |
Immune thrombocytopenia in adults
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Erdal Kurtoğlu and Volkan Karakuş |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Erdal Kurtoğlu, MD, Associated Professor, Department of Hematology, Antalya Training and Research Hospital, Varlık Mah., 07070 Antalya, Turkey. erdalkurtoglu@yahoo.com |
| Key Words |
Immune thrombocytopenia; Splenectomy; Intravenous immunoglobulin; Autoimmune thrombocytopenia |
| Core Tip |
In this manuscript we evaluate all aspects of immune thrombocytopenia (ITP). We outline the etiology, pathogenesis, diagnosis and treatment of ITP. We describe the first and second-line therapies in detail. Also, the mechanism of the actions of drugs is described. |
| Publish Date |
2014-03-26 14:31 |
| Citation |
Kurto?lu E, Karaku? V. Immune thrombocytopenia in adults. World J Immunol 2014; 4(1): 34-41 |
| URL |
http://www.wjgnet.com/2219-2824/full/v4/i1/34.htm |
| DOI |
http://dx.doi.org/10.5411/wji.v4.i1.34 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.